Centro de Investigación Biomédica en Red sobre Epidemiología Y Salud Pública -ko ikertzaileekin lankidetzan egindako argitalpenak (12)

2024

  1. Has COVID-19 Affected DTP3 Vaccination in the Americas?

    Vaccines, Vol. 12, Núm. 3

  2. Summary of the XXX Annual Congress and VI International Congress of the Spanish Society of Neurological Nursing

    Revista Cientifica de la Sociedad Espanola de Enfermeria Neurologica, Vol. 59, pp. 1-5

2022

  1. Prevalence, characteristics, and impact of adverse events in 34 Madrid hospitals. The ESHMAD study

    European Journal of Clinical Investigation, Vol. 52, Núm. 12

2021

  1. Impact of quality of life related to foot problems: a case–control study

    Scientific Reports, Vol. 11, Núm. 1

  2. Variety in fruits and vegetables, diet quality and lifestyle in an older adult mediterranean population

    Clinical Nutrition, Vol. 40, Núm. 4, pp. 1510-1518

2016

  1. Safe Reduction in CD4 Cell Count Monitoring in Stable, Virally Suppressed Patients with HIV Infection or HIV/Hepatitis C Virus Coinfection

    Clinical Infectious Diseases, Vol. 62, Núm. 12, pp. 1578-1585

2014

  1. Predictive factors of severe multilobar pneumonia and shock in patients with influenza

    Emergency Medicine Journal, Vol. 31, Núm. 4, pp. 301-307

2013

  1. Economic Valuation of Health Care Services in Public Health Systems: A Study about Willingness to Pay (WTP) for Nursing Consultations

    PLoS ONE, Vol. 8, Núm. 4

  2. Optimal timing for initiation of highly active antiretroviral therapy in treatment-naïve human immunodeficiency virus-1-infected individuals presenting with AIDS-defining diseases: The experience of the PISCIS Cohort

    Clinical Microbiology and Infection, Vol. 19, Núm. 7, pp. 646-653

  3. Risk factors and effectiveness of preventive measures against influenza in the community

    Influenza and other Respiratory Viruses, Vol. 7, Núm. 2, pp. 177-183

2012

  1. Effectiveness of hand hygiene and provision of information in preventing influenza cases requiring hospitalization

    Preventive Medicine, Vol. 54, Núm. 6, pp. 434-439

2008

  1. Determinants of HIV progression and assessment of the optimal time to initiate highly active antiretroviral therapy: PISCIS cohort (Spain)

    Journal of Acquired Immune Deficiency Syndromes, Vol. 47, Núm. 2, pp. 212-220